Cytotoxic and mutagenic effects of chronic low-dose-rate irradiation on TERT-immortalized human cells. 2005

Hideaki Nakamura, and Hiroko Fukami, and Yuko Hayashi, and Akira Tachibana, and Shigekazu Nakatsugawa, and Michinari Hamaguchi, and Kanji Ishizaki
Central Laboratory and Radiation Biology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan. hnakamu@aichi-cc.jp

To analyze the genetic effects of low-dose-rate radiation on human cells, we used human telomere reverse transcriptase (TERT)-immortalized fibroblast cells obtained from normal individuals. We studied the effect of low-dose-rate (0.3 mGy/ min) and high-dose-rate (2 Gy/min) radiation on cells in a confluent state. Survival and micronucleus induction frequency showed higher resistance after irradiation at low dose rate than at high dose rate. The survival after 5 Gy of high-dose-rate radiation was 0.01 compared to 0.3 after low-dose-rate irradiation at the same dose. In accordance with this, the level of HPRT mutation induction by low-dose-rate radiation decreased to approximately one-eighth that for high-dose-rate radiation. We then characterized the mutants by multiplex PCR analysis, which showed that the fraction of deletion mutations was lower in the mutant cells induced at low dose rate than at high dose rate. Furthermore, the size of the deletions in mutant cells induced by low-dose-rate radiation appeared to be smaller than those in mutant cells irradiated at high dose rate. Only a few exons were deleted in the former mutants while all exons were deleted in most of the latter mutants. The present study indicates that the genetic effects of low-dose-rate radiation on nonproliferating normal human cells are quantitatively and qualitatively less severe than the effect of high-dose-rate radiation.

UI MeSH Term Description Entries
D007041 Hypoxanthine Phosphoribosyltransferase An enzyme that catalyzes the conversion of 5-phosphoribosyl-1-pyrophosphate and hypoxanthine, guanine, or MERCAPTOPURINE to the corresponding 5'-mononucleotides and pyrophosphate. The enzyme is important in purine biosynthesis as well as central nervous system functions. Complete lack of enzyme activity is associated with the LESCH-NYHAN SYNDROME, while partial deficiency results in overproduction of uric acid. EC 2.4.2.8. Guanine Phosphoribosyltransferase,HPRT,Hypoxanthine-Guanine Phosphoribosyltransferase,IMP Pyrophosphorylase,HGPRT,HPRTase,Hypoxanthine Guanine Phosphoribosyltransferase,Phosphoribosyltransferase, Guanine,Phosphoribosyltransferase, Hypoxanthine,Phosphoribosyltransferase, Hypoxanthine-Guanine,Pyrophosphorylase, IMP
D008297 Male Males
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons

Related Publications

Hideaki Nakamura, and Hiroko Fukami, and Yuko Hayashi, and Akira Tachibana, and Shigekazu Nakatsugawa, and Michinari Hamaguchi, and Kanji Ishizaki
January 2008, Journal of radiation research,
Hideaki Nakamura, and Hiroko Fukami, and Yuko Hayashi, and Akira Tachibana, and Shigekazu Nakatsugawa, and Michinari Hamaguchi, and Kanji Ishizaki
September 1991, International journal of radiation oncology, biology, physics,
Hideaki Nakamura, and Hiroko Fukami, and Yuko Hayashi, and Akira Tachibana, and Shigekazu Nakatsugawa, and Michinari Hamaguchi, and Kanji Ishizaki
January 1991, Environmental and molecular mutagenesis,
Hideaki Nakamura, and Hiroko Fukami, and Yuko Hayashi, and Akira Tachibana, and Shigekazu Nakatsugawa, and Michinari Hamaguchi, and Kanji Ishizaki
January 1998, Anticancer research,
Hideaki Nakamura, and Hiroko Fukami, and Yuko Hayashi, and Akira Tachibana, and Shigekazu Nakatsugawa, and Michinari Hamaguchi, and Kanji Ishizaki
September 2004, Radiation research,
Hideaki Nakamura, and Hiroko Fukami, and Yuko Hayashi, and Akira Tachibana, and Shigekazu Nakatsugawa, and Michinari Hamaguchi, and Kanji Ishizaki
May 2007, International journal of radiation biology,
Hideaki Nakamura, and Hiroko Fukami, and Yuko Hayashi, and Akira Tachibana, and Shigekazu Nakatsugawa, and Michinari Hamaguchi, and Kanji Ishizaki
January 2020, Archives of oral biology,
Hideaki Nakamura, and Hiroko Fukami, and Yuko Hayashi, and Akira Tachibana, and Shigekazu Nakatsugawa, and Michinari Hamaguchi, and Kanji Ishizaki
September 1984, International journal of radiation biology and related studies in physics, chemistry, and medicine,
Hideaki Nakamura, and Hiroko Fukami, and Yuko Hayashi, and Akira Tachibana, and Shigekazu Nakatsugawa, and Michinari Hamaguchi, and Kanji Ishizaki
January 1999, Cardiovascular radiation medicine,
Hideaki Nakamura, and Hiroko Fukami, and Yuko Hayashi, and Akira Tachibana, and Shigekazu Nakatsugawa, and Michinari Hamaguchi, and Kanji Ishizaki
November 2015, Lasers in surgery and medicine,
Copied contents to your clipboard!